Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...
Goldman Sachs updated its price target on AstraZeneca (NASDAQ:AZN:LN) (NASDAQ: AZN) shares to GBP150.67, down from GBP155.58, while reaffirming a Buy rating on the stock. The adjustment follows a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback